Goodwin Biotechnology is a leading biological Contract Manufacturing Organization (CMO) that offers
a full range of mammalian cell culture services ranging from the creation of up
and downstream processes sufficient for the manufacturing of proof of concept,
toxicology product material and processes for licensed manufacturing.
Goodwin Biotechnology works with most mammalian cell lines used for manufacturing, including CHO, NS/0, BHK, 293 as well as murine hybridomas, and all selection systems used with these lines. They also work with several different selection systems such as dhfr - /methotrexate CHO, mycophenolic acid/xanthine, and G418 systems. Their experience includes surface dependent as well as suspension culture types.
Goodwin’s clients are global and include biotech startup firms, research institutes, universities, multinational biotechnology and pharmaceutical companies, and government institutes with projects from translational medicine to producing materials for clinical trials
C ell Line Development
Goodwin
Biotechnology scientists, many of whom are PhDs, have considerable
experience in the development of cell lines for cGMP manufacturing for clinical
studies through commercial manufacturing. In addition, working with their
partners, Goodwin can develop cell lines from cDNA that you provide. Goodwin’s
partners offer their own proprietary vectors to develop cell lines that can
routinely produce up to 4g/L in CHO cell lines.
Cell Banking
Goodwin
Biotechnology offers a full array cell banking services for research or
manufacturing use. Manufacturing banks include seed, master, working, and post
production. All of these banks are GMP compliant and are tested based on the
current Points to Consider for cell bank testing. Goodwin Biotechnology works
closely with their clients and with our qualified contract testing
organizations to assure acceptability of all testing. Banks are prepared using
a controlled freeze rate system and are stored in -150°C mechanical freezer
systems. All bank inventories are secured and controlled by Goodwin
Biotechnology’s Quality department. Short- or long-term storage of cell banks
is provided.
·
Research Cell Banks can be made
at Goodwin Biotechnology to carry out non-GMP process development activities.
·
Goodwin Biotechnology produces Master
Cell Banks (MCBs) and Working Cell Banks (WCBs) in compliance with cGMP
requirements.
Cell Culture Process Development
Goodwin
Biotechnology will develop a robust and reproducible cell culture process for
the production of complex therapeutic protein drug candidates. Goodwin
Biotechnology has experience with a number of cell cultivation technologies
including stationary culture disposable flasks, spinners, WAVE disposable and
stirred tank bioreactors. Goodwin Biotechnology offers cell culture production
services for non-bioreactor projects.
·
Media selection and development (both
animal component and animal-free components)...
Goodwin Biotechnology offers medium evaluation and adaptation to commercial
serum free formulations for your cell line. Goodwin’s goal is to increase your
line's productivity, growth performance, and/or compliance level.
·
Development and optimization of robust
and scalable processes... Goodwin Biotechnology offers three
different types of bioreactor systems for production and process development
services for each. Goodwin works with clients to determine the optimum
bioreactor type to use for their project based on their cell expression system
and product quantities needed.
·
Stirred tank batch or fed-batch
bioreactor... Stirred tank bioreactors up to 500L
are available. With the possibility of achieving yields up to three grams per
liter, Goodwin’s bioreactors produce up to 1,500 grams per every 8 to 10 day
run.
·
Fibracell disk immobilized bed
perfusion bioreactors...
Bioreactors with cartridge surface areas ranging from 2.1 to 25.2m² are available. The larger of these bioreactors can produce in excess of 150 grams during a six-week production run.
Bioreactors with cartridge surface areas ranging from 2.1 to 25.2m² are available. The larger of these bioreactors can produce in excess of 150 grams during a six-week production run.
·
Hollow fiber
·
6 X 5L Sartorius Bioreactors...
Goodwin Biotechnology has available small bioreactor systems of each type for
the development of specific run parameters and scaling data for the larger production
bioreactors. These small systems are also available for the production of
non-GMP material for testing and toxicology studies.
Cell Culture Process Development
Goodwin
Biotechnology will develop a robust and reproducible cell culture process for the
production of complex therapeutic protein drug candidates. Goodwin
Biotechnology has experience with a number of cell cultivation technologies
including stationary culture disposable flasks, spinners, WAVEdisposable and
stirred tank bioreactors. Goodwin Biotechnology offers cell culture production
services for non-bioreactor projects.
·
Media selection and development (both
animal component and animal-free components)...
Goodwin Biotechnology offers medium evaluation and adaptation to commercial
serum free formulations for your cell line. Their goal is to increase your
line's productivity, growth performance, and/or compliance level.
·
Development and optimization of robust
and scalable processes... Goodwin Biotechnology offers three
different types of bioreactor systems for production and process development
services for each. Goodwin works with clients to determine the optimum
bioreactor type to use for their project based on the
cell expression system and product quantities needed.
·
Stirred tank batch or fed-batch
bioreactor... Stirred tank bioreactors up to 500L
are available. With the possibility of achieving yields up to three grams per
liter, Goodwin’s bioreactors produce up to 1,500 grams per every 8 to 10 day
run.
·
Fibracell disk immobilized bed
perfusion bioreactors...
Bioreactors with cartridge surface areas ranging from 2.1 to 25.2m² are available. The larger of these bioreactors can produce in excess of 150 grams during a six-week production run.
Bioreactors with cartridge surface areas ranging from 2.1 to 25.2m² are available. The larger of these bioreactors can produce in excess of 150 grams during a six-week production run.
·
Hollow fiber
·
6 X 5L Sartorius Bioreactors...
Goodwin Biotechnology has available small bioreactor systems of each type for
the development of specific run parameters and scaling data for the larger
production bioreactors. These small systems are also available for the production
of non-GMP material for testing and toxicology studies.
No comments:
Post a Comment